Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06422897
Other study ID # 1133/04/2024
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 15, 2024
Est. completion date June 5, 2024

Study information

Verified date May 2024
Source Minia University
Contact Ahmed A Abdelghany, professor
Phone 00201020009630
Email ahmeda.abdelghany82@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Assessment of healing of thin and perforated cornea after surgical treatment by anterior segment optical coherence tomography


Description:

- thin and perforated cornea (small perforation) is surgically treated by amniotic membrane graft and platelet rich plasma clot - anterior segment optical coherence tomography is performed preoperative and 1 month postoperative to assess healing


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date June 5, 2024
Est. primary completion date May 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - thin cornea about to perforate - small corneal perforation Exclusion Criteria: - active infection

Study Design


Related Conditions & MeSH terms


Intervention

Other:
anterior segment optical coherence tomography
surgically treated corneal perforation by amniotic membrane graft and platelet rich plasma clot is assessed by anterior segment optical coherence tomography 1 month postoperative

Locations

Country Name City State
Egypt Faculty of Medicine Minya

Sponsors (1)

Lead Sponsor Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Abdelghany AA, Bahrawy ME, Alio JL. Combined Platelet Rich Plasma and Amniotic membrane in the treatment of Perforated Corneal Ulcers. Eur J Ophthalmol. 2022 Jul;32(4):2148-2152. doi: 10.1177/11206721211049100. Epub 2021 Oct 8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary healing complete corneal healing 1 month
See also
  Status Clinical Trial Phase
Completed NCT04820010 - Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
Terminated NCT02116062 - Robotic Surgery of the Ocular Surface N/A
Completed NCT03500796 - Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation N/A